For these analyses, we excluded tumor-associated markers expressed in more than 90% (CK7, CK19, CKLMW, CKHMW, and MUC1) or less than 10% (vimentin and MUC2) of the tumor samples. This evidence concerns the gene KRT19 and neoplasm.